Form D · Biotechnology
BioCytics, Inc.
Huntersville, NC · CIK 0001971839
Offering snapshot reported Mar 13, 2026 · SEC filing
- Reported sold
- $25K Offering amount: $7M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jan 2, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 13, 2026 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Dec 28, 2023 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Mar 31, 2023 | Initial | $1,355,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-576448
Source: Form D, filed Mar 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Don L. Jackson | Executive |
| Matthew Pietras | Executive |
| John Powderly | Director, Executive |
| Jim Powderly | Executive |
| Stacy Powderly | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9801 Kincey Ave. Suite 145
Huntersville, NC, 28078
Huntersville, NC, 28078